Literature DB >> 14743398

Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5.

Meena R Sharma1, George P Tuszynski, Mahesh C Sharma.   

Abstract

Endothelial cells (ECs) are quiescent in normal blood vessels, but undergo rapid bursts of proliferation after vascular injury, hypoxia or induced by powerful angiogenic cytokines like fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF). Deregulated proliferation of ECs facilitates angiogenic processes and promotes tumor growth. In dividing cells, cell cycle-associated protein kinases, which are referred as cyclin-dependent kinases (cdks), regulate proliferation, differentiation, senescence, and apoptosis. Cyclin-dependent kinase-5 (cdk5) is expressed in neuronal cells and plays an important role in neurite outgrowth, of neuronal migration and neurogenesis, its functions in non-neuronal cells are unclear. Here, we show for the first time that the cdk5 is expressed at high levels in proliferating bovine aortic endothelial (BAE) cells, by contrast insignificant low levels of cdk5 expression in quiescent BAE cells. In addition, bFGF up-regulates cdk5 expression in a dose-dependent fashion. Interestingly, temporal expression data suggests that cdk5 expression is very low between 24-48 h, but high level of cdk5 expression was detected during 60-72 h. This later time corresponds to the time of completion of one cell cycle (doubling of cell population) of BAE cell culture. Angiostatin (AS), a powerful inhibitor of angiogenesis inhibits ECs proliferation in dose-dependent manner with concomitant down-regulation of cdk5 expression. The role of cdk5 in ECs, proliferation and apoptosis was confirmed by selective inhibition of cdk5 expression by the purine derivative roscovitine, which inhibits bFGF-stimulated BAE cells proliferation and induces apoptosis in dose-specific manner. By contrast, the roscovitine analog olomoucine, which is a specific inhibitor of cdk4, but not of cdk5 failed to affect ECs proliferation and apoptosis. These data suggest for the first time that neuron specific protein cdk5 may have significant role in the regulation of ECs proliferation, apoptosis, and angiogenesis and extends beyond its role in neurogenesis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743398     DOI: 10.1002/jcb.10762

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  19 in total

1.  Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery.

Authors:  H M C Shantha Kumara; Samer T Tohme; Xiaohong Yan; Abu Nasar; Anthony J Senagore; Matthew F Kalady; Neil Hyman; Ik Y Kim; Richard L Whelan
Journal:  Surg Endosc       Date:  2010-12-22       Impact factor: 4.584

2.  Role of Angiogenesis in Chronic Radiation Proctitis: New Evidence Favoring Inhibition of Angiogenesis Ex Vivo.

Authors:  Peihuang Wu; Li Li; Huaiming Wang; Tenghui Ma; Haiyong Wu; Xinjuan Fan; Zihuan Yang; Daici Chen; Lei Wang
Journal:  Dig Dis Sci       Date:  2017-10-27       Impact factor: 3.199

3.  MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.

Authors:  Srikanth Givvimani; Neetu Tyagi; Utpal Sen; Paras K Mishra; Natia Qipshidze; Charu Munjal; Jonathan C Vacek; Oluwasegun A Abe; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2010-05       Impact factor: 4.076

Review 4.  The Emerging Role of Cdk5 in Cancer.

Authors:  Karine Pozo; James A Bibb
Journal:  Trends Cancer       Date:  2016-10

5.  Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation.

Authors:  Neel R Sodha; Richard T Clements; Munir Boodhwani; Shu-Hua Xu; Roger J Laham; Cesario Bianchi; Frank W Sellke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-12       Impact factor: 4.733

6.  Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.

Authors:  Tracy Dodd; Luke Wiggins; Rebecca Hutcheson; Erika Smith; Alla Musiyenko; Brenda Hysell; James C Russell; Petra Rocic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311

7.  Insulin treatment enhances the myocardial angiogenic response in diabetes.

Authors:  Munir Boodhwani; Neel R Sodha; Shigetoshi Mieno; Basel Ramlawi; Shu-Hua Xu; Jun Feng; Richard T Clements; Marc Ruel; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2007-11-05       Impact factor: 5.209

8.  Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients.

Authors:  Neel R Sodha; Munir Boodhwani; Richard T Clements; Shu-Hua Xu; Kamal R Khabbaz; Frank W Sellke
Journal:  Arch Surg       Date:  2008-05

9.  Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease.

Authors:  Kai-Hui Sun; Yolanda de Pablo; Fabien Vincent; Emmanuel O Johnson; Angela K Chavers; Kavita Shah
Journal:  Mol Biol Cell       Date:  2008-05-14       Impact factor: 4.138

10.  Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism.

Authors:  Wei Mu; David A Long; Xiaosen Ouyang; Anupam Agarwal; Pedro E Cruz; Carlos A Roncal; Takahiko Nakagawa; Xueqing Yu; William W Hauswirth; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.